Aspirin intolerance. III. Subtypes, familial occurence, and cross-reactivity with tartarazine
about
sameAs
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthmaGenetics and pharmacogenetics of the leukotriene pathwayAn analysis of the role of IgE in intolerance to aspirin and tartrazineDrug-induced pulmonary disease.Reactions to dietary tartrazineTartrazine in atopic eczema.Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.Recurrent urticaria.Hypersensitivity reactions to food additives.A review of the specifications and toxicity of synthetic food colors permitted in Canada.Clinical spectrum of adverse reactions to tartrazine.Analgesic-antipyretic choices for children with asthma: a review of safety and risk of common preparations.Incidence of intolerance to food additives.Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review.The intranasal ethmoidectomy: evolution and an assessment of the procedure.Urticaria and angioedema. Common clinical problems.Tartrazine: a potentially hazardous dye in Canadian drugsSensitivity to tartrazine.'Immunogenic impurities' in acetylsalicylic acid.Allergy, learning, and behavior problems.
P2860
Q28189893-BD763A03-C6D5-4E78-9DE0-86C7628DB8DFQ28254268-4A38CF44-B7FF-45AF-A6FF-B038CCBA5EE3Q28324555-615A4E48-1ED9-4215-A3E6-4297B8D1ED6CQ33759641-1F8F64BC-6363-45EA-864E-37ADE3739F5CQ35603601-57022B84-F83D-4332-9C37-0E43038A8B5FQ35628279-5C378B63-2362-4E28-8F34-1E71A7846739Q37757325-E0D50BB7-291B-484D-B7C7-E4172305EADEQ39093777-BDCA30FA-D7BD-4E38-A1A2-E1FAF686B341Q39689003-5A567E1F-C3AE-49E3-8068-8A85A1F9AFB5Q39785480-F14EE924-C6F0-455A-A186-20048A8D7309Q39824995-1E4AC34C-F7D1-4B76-80B3-8B71513035E1Q40214906-FCD0A911-E241-4602-BC6B-1A1A4297464AQ40297081-C2E90A72-5DA9-4AF6-B212-D8AD412187DAQ40361676-1B2F4C95-9312-4C62-B699-24EFF9BAF9E2Q40758616-4C2612E1-DEB1-44AC-AF02-A6B305F45A20Q41463783-8402C639-F0A0-47CC-A7EA-B3C029F719B9Q41859666-04D3B406-03CC-4B0C-B596-3B71343FCB33Q42333605-14F8F5F4-1BAB-4928-8792-23C4CE93BBE2Q45369873-A4983EB7-1166-44C6-B749-857D441A0473Q52302883-B1BCEA64-69EC-46B8-B6D6-0E9B8BB463C7
P2860
Aspirin intolerance. III. Subtypes, familial occurence, and cross-reactivity with tartarazine
description
1975 nî lūn-bûn
@nan
1975 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@ast
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@en
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@nl
type
label
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@ast
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@en
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@nl
prefLabel
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@ast
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@en
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@nl
P1476
Aspirin intolerance. III. Subt ...... ss-reactivity with tartarazine
@en
P2093
G A Settipane
R K Pudupakkam
P304
P356
10.1016/0091-6749(75)90092-5
P407
P577
1975-09-01T00:00:00Z